Qualitative study of oncologists’ perceptions on the US Food and Drug Administration approval status and clinical practice guidelines and their impact on local practice patterns in India
Oncologists in India demonstrated awareness of the limitations of the US FDA drug approvals and found resource-stratified guidelines to be unhelpful. They preferred the main guidelines and institutional protocols over resource-stratified guidelines.
Authors
- Soumitra Shankar Datta (ORCID: https://orcid.org/0000-0003-1674-5093)
- Bhawna Sirohi (ORCID: https://orcid.org/0000-0001-8093-1531)
- Bishal Gyawali (ORCID: https://orcid.org/0000-0001-7444-8594)
- Sanjit Kumar Agrawal (ORCID: https://orcid.org/0000-0002-3561-4534)
- Varuna Sharma
- Arnab Mukherjee (ORCID: https://orcid.org/0000-0002-6325-7116)
Institutions
- Ontario Institute for Cancer Research (CA)
- Queen's University (CA)
- Tata Medical Center (IN)
- MRC Clinical Trials Unit at UCL (GB)
- University College London (GB)
Publication Details
- Journal
- BMJ Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjonc-2025-000863
- Citations
- 1
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Government of Ontario